Bangladéš - angličtina - DGDA (Directorate General of Drug Administration)

royel laboratories (ay) - sanjiban modak - modak

Bangladéš - angličtina - DGDA (Directorate General of Drug Administration)

s. b. laboratories (ayurvedic) - sukrasanjibani modak - modak

Izrael - angličtina - Ministry of Health

rafa laboratories ltd - sulpiride - capsules - sulpiride 50 mg - sulpiride - sulpiride - anti - dopaminergic agent for use in vertigo and prepsychotic states.

Izrael - angličtina - Ministry of Health

rafa laboratories ltd - sulpiride - tablets - sulpiride 200 mg - sulpiride - sulpiride - anti - dopaminergic agent. 1) for use in vertigo and prepsychotic states. 2) at high doses - in psychiatric patients for treatment of depression and apathy.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

gamma gurus pty ltd - 40624 - multi-modality therapeutic radiation phantom, anthropomorphic - multi-modality therapeutic radiation phantom, anthropomorphic

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - nitrofurantoin, quantity: 100 mg - capsule, hard - excipient ingredients: maize starch; purified talc; lactose monohydrate; gelatin; quinoline yellow; titanium dioxide; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; simethicone - indications as at 1 january 1991 : treatment of urinary tract infections such as cystitis and pyelitis when due to susceptible pathogens. nitrofurantoin does not reach effective levels in plasma and consequently is not indicated for cortical or perinephric abscesses and in cases of prostatitis.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - nitrofurantoin, quantity: 50 mg - capsule, hard - excipient ingredients: gelatin; maize starch; quinoline yellow; titanium dioxide; lactose monohydrate; purified talc; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - indications as at 1 january 1991 : treatment of urinary tract infections such as cystitis and pyelitis when due to susceptible pathogens. nitrofurantoin does not reach effective levels in plasma and consequently is not indicated for cortical or perinephric abscesses and in cases of prostatitis.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

soma lasers australia - 45220 - multi-modality skin surface treatment system - multi-modality skin surface treatment system combines a variety of light-energy modalities used for ablative and non-ablative application treatments of the skin surface: tattoo removal; birth mark removal; red and brown pigment; eliminate coffee spot and taitian naevus; eyebrow-cleaning and eye-line-cleaning